Skip to content

Surgical Management for Suburethral Slings

Prospective, Non-Randomized, Observational Trial of the Surgical Management for Suburethral Slings in Women With Stress Urinary Incontinence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02785016
Enrollment
100
Registered
2016-05-27
Start date
2013-05-01
Completion date
2025-12-01
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Keywords

Stress Urinary Incontinence, Suburethral Sling

Brief summary

This is a prospective, non-randomized, observational, single center study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a suburethral sling operative procedure.

Detailed description

The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires. Intraoperative procedural data will be collected. Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals. The anatomic position of the device will be characterize by introital ultrasound testing.

Interventions

None listed

Sponsors

Cantonal Hospital, Frauenfeld
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient has objective demonstrable signs of stress urinary incontinence (SUI), including patients with intrinsic sphincter deficiency (ISD). Objective testing includes: standing stress test, urodynamics evaluation, or pad test. 2. Patient is age 18 or older. 3. Patient agrees to participate in the study, including completion of all study-related procedures and evaluations, and documents this agreement by signing the IRB/EC-approved informed consent. 4. Patient is able to fill in all questionnaires (on judgement of investigator)

Exclusion criteria

1. Patient has an associated or suspected neurological disease. 2. Patient has an active lesion or present injury to perineum or urethra. 3. Patient has a urethral obstruction. 4. Patient has significant pelvic organ prolapse (Grade III/IV) requiring surgical treatment. 5. The subject has current urinary tract infection.

Design outcomes

Primary

MeasureTime frameDescription
Cure/improvement rate3 monthsPatients are classified as cured if the postoperative cough test (see Outcome 4 below) is negative and the degree of subjective suffering (see Outcome 2 below) improves to over 90% (VAS score of 0 or 1). Criteria for improvement are involuntary loss of only a few drops of urine during straining and an improvement of the degree of suffering to over 75% (VAS score of 2 or 3). All other patients are classified as therapeutic failures (even if they show marked improvement of one of the parameters compared with their preoperative status).

Secondary

MeasureTime frameDescription
Subjective symptom assessment by visual analogue scale3 and 6 monthsScale: 0-10 (0-no suffering, 10-severe suffering)
Post-Operative Pain Assessment1 dayScale: 0-10 (0-no pain, 10-severe pain)
Standing Cough Stress Testbaseline, 3 and 6 months3 categories: negative/severe, if flow of urine is observed. negative/mild, if the loss of only a few drops is observed. positive, if no urine loss occurs.
King Health Questionnairepre-operation, 3 and 6 months
International Consultation on Incontinence Questionnairepre-operation, 3 and 6 months

Countries

Switzerland

Contacts

PRINCIPAL_INVESTIGATORVolker Viereck, Physican

Cantonal Hospital, Frauenfeld

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026